Biotech news for Tuesday, May 12, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Earnings Call Insights: Kyntra Bio (KYNB) Q1 2026 Management View CEO Thane Wettig said the quarter’s focus remained on “consistent progress we have made across our portfolio,” highlighting “FG-3246, our potential first-in-class antibody drug conjugate targeti…
MacroGenics ( MGNX ) said on Monday it agreed to sell its GMP drug substance manufacturing operations to Bora Pharmaceuticals Co., Ltd. for $122.5 million upfront. The deal includes MacroGenics’ manufacturing facilities in Rockville and Frederick, Maryland, as…
Mohammed Haneefa Nizamudeen BridgeBio Pharma ( BBIO ) is down ~4% in Monday trading despite releasing phase 3 heart failure data for Attruby ( acoramidis). Results from the ATTRibute-CM study found that the drug led to consistent and clinically meaningful bene…
Earnings Call Insights: Heron Therapeutics (HRTX) Q1 2026 Management View “Total net sales of $34.7 million in Q1,” including “ZYNRELEF at $10.2 million, APONVIE at $3.4 million; on the oncology side, $21.1 million combined: CINVANTI at $20.5 million, SUSTOL a…
Earnings Call Insights: Bicara Therapeutics (BCAX) Q1 2026 Management View "The first quarter of 2026 set a strong foundation for the year ahead" and the company reiterated its focus on advancing ficerafusp alfa (ficera) in "HPV-negative first-line head and ne…
MF3d Bitcoin ( BTC-USD ) prices gradually rose to the $70K mark in April amid uncertainty over developments in Iran. Analysts remain mixed over the cryptocurrency’s further movement this year, with odds roughly split that BTC will rise back to $100K in 2026, a…
AnaptysBio ( ANAB ) on Monday announced the appointment of Christopher Murphy as Chief Financial Officer. Murphy, previously, served as CFO and CBO of Third Harmonic Bio. Before Third Harmonic, he served as a senior leader at Horizon Therapeutics. The company…
jittawit.21 Erasca ( ERAS ) on Monday announced a clinical trial collaboration and supply agreement (CTCSA) with Merck ( MRK ), known as MSD outside the United States and Canada, sending shares up ~8% in early trading. This agreement supports a clinical proof-…
Zai Lab ( ZLAB ) said the U.S. FDA granted fast track designation to its experimental cancer drug zocilurtatug pelitecan for treating extrapulmonary neuroendocrine carcinomas after standard first-line treatment fails. Preliminary clinical data recently present…
Alvotech ( ALVO ) Monday said that the U.S. Food and Drug Administration (FDA) has completed a routine cGMP surveillance inspection of the company’s manufacturing facility in Reykjavik, Iceland, sending shares up 1.5% in premarket trading. After the inspection…
fengdr Here's a list of key deals reported across sectors this week: Two Harbors Investment ( TWO ) agreed to an amended merger agreement with CrossCountry Mortgage, increasing the all-cash deal to $12 a share from $11.30. Roche ( RHHBF ) announced on Thursday…
Quant rankings for the upcoming earnings calendar show strength concentrated across financials, consumer discretionary, and select industrial names, while weakness is more pronounced in health care and pockets of information technology. A total of 836 companie…
Grandbrothers/iStock Editorial via Getty Images The U.S. FDA has approved a label expansion for Vyvgart and Vyvgart Hytrulo in myasthenia gravis, letting a broader section of adults suffering from the autoimmune disease receive the therapy, its manufacturer, a…
Earnings Call Insights: ALX Oncology (ALXO) Q1 2026 Management view "Most notably, we are very excited to share with you the data set that was presented yesterday in Munich at ESMO Breast 2026 from the analysis of our trial evaluating evorpacept
Earnings Call Insights: Vaxart (VXRT) Q1 2026 Management View “In the first quarter, we made meaningful progress advancing our clinical programs and preparing for key data milestones that we believe will help demonstrate the value of our oral vaccine platform.…
Andrii Dodonov/iStock via Getty Images HHS officials recently discussed whether to ban selective serotonin reuptake inhibitors (SSRIs), among the most popular antidepressant medications prescribed, amid a push to reduce the use of the drugs. The development, w…
Smederevac Inhibrx Biosciences ( INBX ) is up ~4% in after-hours trading Friday after announcing it will release interim results on May 11 from a phase 2 trial of INBRX-106 for first-line h ead and neck squamous cell carcinoma. The data is examining INBRX-106